Geojit Financial Services has reaffirmed a BUY rating on Aurobindo Pharma Limited with a target price of Rs 1,540, implying a potential upside of 25% from the current market price of Rs 1,229.
Laurus Labs, a major player in the pharmaceutical and biotechnology space, has been gaining traction among investors due to its strong fundamentals and sectoral potential.
KRChoksey Research reiterates its BUY recommendation for Balaji Amines Ltd with a revised target price of Rs 2,328, reflecting a potential upside of 16.6% from the current market price of Rs 1,996.